Refine
Has Fulltext
- yes (57)
Is part of the Bibliography
- yes (57)
Year of publication
Document Type
- Journal article (57) (remove)
Language
- English (57)
Keywords
- blood vessel (3)
- cancer (3)
- inflammation (3)
- organoid (3)
- TGFβ signaling (2)
- angiogenesis (2)
- diabetic retinopathy (2)
- expression (2)
- extracellular matrix (2)
- in vitro (2)
Institute
- Institut für Anatomie und Zellbiologie (57)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (11)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (5)
- Klinik und Poliklinik für Unfall-, Hand-, Plastische und Wiederherstellungschirurgie (Chirurgische Klinik II) (4)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (3)
- Medizinische Klinik und Poliklinik I (3)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (2)
- Graduate School of Life Sciences (2)
- Institut für Experimentelle Biomedizin (2)
- Institut für Pharmakologie und Toxikologie (2)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 701983 (1)
B cell aggregates in the central nervous system (CNS) have been associated with rapid disease progression in patients with multiple sclerosis (MS). Here we demonstrate a key role of carcinoembryogenic antigen-related cell adhesion molecule1 (CEACAM1) in B cell aggregate formation in MS patients and a B cell-dependent mouse model of MS. CEACAM1 expression was increased on peripheral blood B cells and CEACAM1\(^+\) B cells were present in brain infiltrates of MS patients. Administration of the anti-CEACAM1 antibody T84.1 was efficient in blocking aggregation of B cells derived from MS patients. Along these lines, application of the monoclonal anti-CEACAM1 antibody mCC1 was able to inhibit CNS B cell aggregate formation and significantly attenuated established MS-like disease in mice in the absence of any adverse effects. CEACAM1 was co-expressed with the regulator molecule T cell immunoglobulin and mucin domain −3 (TIM-3) on B cells, a novel molecule that has recently been described to induce anergy in T cells. Interestingly, elevated coexpression on B cells coincided with an autoreactive T helper cell phenotype in MS patients. Overall, these data identify CEACAM1 as a clinically highly interesting target in MS pathogenesis and open new therapeutic avenues for the treatment of the disease.